Congratulations to Carlha Gutierrez, Monica Otero and Laura Sanchez for obtaining the first award of IDEALUGO
This award was given by El Progreso, Abanca, and the USC.
The project involves the creation of a company based on the exploitation of services created by researchers from our Group (ZebraBioRes).
The company will focus its activities on providing toxicity and efficacy assessment services for compounds, especially nanocomposites, in an innovative and recent model organism, the Zebrafish. This model has many advantages compared to other model organisms, offering our services a wonderful distinction to provide valuable information more quickly and low cost. In addition, as a short-term R & D plan, the company will offer anti-tumor efficacy trials (using xenotransplants in the zebrafish) to Oncology patients. These studies will provide patients with the possibility of knowing in a short time the most suitable antitumor for their condition.